Dr. Martens (DOCS)

Sector:

Personal Goods

Index:

FTSE 250

89.65p
   
  • Change Today:
    -1.25p
  • 52 Week High: 99.35
  • 52 Week Low: 47.52
  • Currency: UK Pounds
  • Shares Issued: 967.06m
  • Volume: 689,609
  • Market Cap: £866.97m
  • Beta: 1.20

Dr. Martens Overview

Dr. Martens operates in the global footwear market. Statista estimates that global retail sales of footwear in 2019 were £341 billion representing 12 billion pairs of footwear. Dr. Martens has a diversified global presence, with sales in more than 60 countries. The Group’s current geographical footprint, in terms of total Group revenue, is more weighted towards the US and EMEA, with APAC representing 20% of Dr. Martens’ FY20 revenue as compared to 29% for retail sales of the entire footwear market.

Key Personnel

CEO: Ije Nwokori
CFO: Giles Wilson
Chairman: Paul Mason
Independent Non-Executive Director: Ian Rogers
Independent Non-Executive Director: Andrew Harrison
Independent Non-Executive Director: Robyn Perriss
Senior Independent Non-Executive Director: Lynne Weedall
Non-Executive Dir: Robert Hanson , Tara Alhadef, Benoit Vauchy

Contact Details

Address: 28 Jamestown Road, Camden, London, United Kingdom, NW1 7BY
Website: http://www.drmartensplc.com

Listings

Sector: Personal Goods(LSE)
Index: FTSE 250, FTSE 350, FTSE All-Share
ISIN: GB00BL6NGV24

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Dr. Martens Market Data

Currency UK Pounds
Share Price 89.65p
Change Today -1.25p
% Change -1.38 %
52 Week High 99.35
52 Week Low 47.52
Volume 689,609
Shares Issued 967.06m
Market Cap £866.97m
Beta 1.20

Dr. Martens Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
28.38% below the market average28.38% below the market average28.38% below the market average28.38% below the market average28.38% below the market average
77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average
Price Trend
32.86% above the market average32.86% above the market average32.86% above the market average32.86% above the market average32.86% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income
48.6% below the market average48.6% below the market average48.6% below the market average48.6% below the market average48.6% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
99.52% below the market average99.52% below the market average99.52% below the market average99.52% below the market average99.52% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Dr. Martens Dividends

  Latest Previous
  Final Interim
Ex-Div 28-Aug-25 06-Mar-25
Paid 08-Oct-25 08-Apr-25
Amount 1.70p 0.85p

Trades for 03-Nov-2025

Time Volume / Share Price
15:31 2 @ 89.15p
15:31 4 @ 89.15p
15:00 23 @ 89.40p
15:00 12 @ 89.40p
14:53 1 @ 89.50p

Dr. Martens Key Personnel

Chair Paul Mason
CEO Ije Nwokori
CFO Giles Wilson

Top of Page